Compare QSI & LDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QSI | LDP |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.7M | 628.4M |
| IPO Year | N/A | N/A |
| Metric | QSI | LDP |
|---|---|---|
| Price | $1.22 | $21.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $2.88 | N/A |
| AVG Volume (30 Days) | ★ 4.3M | 102.5K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.91% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,177,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $159.68 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 40.20 | N/A |
| 52 Week Low | $0.95 | $16.16 |
| 52 Week High | $5.77 | $20.30 |
| Indicator | QSI | LDP |
|---|---|---|
| Relative Strength Index (RSI) | 37.52 | 41.84 |
| Support Level | $1.18 | $21.26 |
| Resistance Level | $1.54 | $21.44 |
| Average True Range (ATR) | 0.10 | 0.17 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 15.28 | 11.84 |
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.